AMVUTTRA
NDC 71336-1003, VUTRISIRAN, injection, from Alnylam Pharmaceuticals, Inc..
- Product NDC
- 71336-1003
- Status
- Listed
- Labeler
- Alnylam Pharmaceuticals, Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215515
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VUTRISIRAN SODIUM25 mg/.5mL
Pharmacologic classes
Decreased RNA Integrity [PE]; Increased Protein Breakdown [PE]; RNA, Small Interfering [CS]; Small Interfering RNA [EPC]; Transthyretin-directed RNA Interaction [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71336-1003-1 | 71336100301 | 1 SYRINGE, GLASS in 1 CARTON (71336-1003-1) / .5 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8db0facb-81b6-4006-9239-27dc6409c5d3Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=71336-1003
Use it
Look up 71336-1003 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71336-1003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.